Heron Therapeutics Inc (HRTX)
3.20
-0.02
(-0.62%)
USD |
NASDAQ |
May 17, 16:00
3.20
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Accounts Receivable (Quarterly): 65.32M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 65.32M |
December 31, 2023 | 60.14M |
September 30, 2023 | 63.80M |
June 30, 2023 | 76.69M |
March 31, 2023 | 51.45M |
December 31, 2022 | 52.05M |
September 30, 2022 | 42.19M |
June 30, 2022 | 40.30M |
March 31, 2022 | 41.10M |
December 31, 2021 | 35.50M |
September 30, 2021 | 43.09M |
June 30, 2021 | 42.62M |
March 31, 2021 | 38.52M |
December 31, 2020 | 41.85M |
September 30, 2020 | 33.65M |
June 30, 2020 | 37.50M |
March 31, 2020 | 34.81M |
December 31, 2019 | 39.88M |
September 30, 2019 | 66.96M |
June 30, 2019 | 66.82M |
March 31, 2019 | 74.01M |
December 31, 2018 | 64.65M |
September 30, 2018 | 53.63M |
June 30, 2018 | 45.89M |
March 31, 2018 | 37.71M |
Date | Value |
---|---|
December 31, 2017 | 41.87M |
September 30, 2017 | 28.85M |
June 30, 2017 | 18.62M |
March 31, 2017 | 10.33M |
December 31, 2016 | 1.96M |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | 0.00 |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
33.65M
Minimum
Sep 2020
76.69M
Maximum
Jun 2023
48.71M
Average
42.40M
Median
Accounts Receivable (Quarterly) Benchmarks
United Therapeutics Corp | 307.30M |
Ligand Pharmaceuticals Inc | 28.44M |
Esperion Therapeutics Inc | 54.61M |
Aldeyra Therapeutics Inc | -- |
Ionis Pharmaceuticals Inc | -- |